Skip to content

Measurement of gait variability in patients with and without hemophilic arthropathy; MOVE study

Measurement of gait variability in patients with and without hemophilic arthropathy; MOVE study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22693
Enrollment
100
Registered
2014-02-13
Start date
2014-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemophilia, gait pattern, arthropathy, gaitSMART, footwear hemofilie, looppatroon, artropathie, gaitSMART, schoeisel

Interventions

Gait analysis with a new, simple and quick device. The six sensors of this system will be mounted on both sides of the hip, on the lateral side of the lower limbs using straps around thigh (just below

Sponsors

Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, the Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: − Patients with mild, moderate or severe hemophilia A or B − Age >12 years − No clinical evidence of a recent joint or muscle bleed; no joint or muscle bleed at least 30 days prior to inclusion

Exclusion criteria

Exclusion criteria: − Inability to walk 20 meters without use of assistive devices − Joint replacement in knee, ankle or hip − Arthrodesis of foot and ankle joints

Design outcomes

Primary

MeasureTime frame
Disturbed gait pattern detected with sensor based gait analysis system, defined as % of difference in range of motion, quality of gait and symmetry of gait compared to the reference population.

Secondary

MeasureTime frame
− Number (%) of patients with Hemophilia Joint Health Score=0 and a disturbed gait pattern as defined above. − Differences in outcome parameters of the gait analysis barefoot, on standardized walking shoes and on own shoes.

Contacts

Public ContactS.C.M. Stoof

Erasmus MC

s.stoof@erasmusmc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)